When Will Heron Therapeutics, Inc. (NASDAQ:HRTX) Turn A Profit? [Yahoo! Finance News]
Heron Therapeutics, Inc. (HRTX)
Last heron therapeutics, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
herontherapeutics.gcs-web.com/investor-home
Company Research
Source: Yahoo! Finance News
Heron Therapeutics, Inc.'s NASDAQ:HRTX See our latest analysis for Heron Therapeutics Consensus from the 10 Biotechs analysts is HRTX is on the verge of breakeven. They expect the company to post a final loss in 2021, before turning a profit of US$69m in 2022. Therefore, HRTX is expected to breakeven roughly 3 years from today. What rate will HRTX have to grow year-on-year in order to breakeven on this date? Using a line of best fit, I calculated an average annual growth rate of 70%, which signals high confidence from analysts. If this rate turns out to be too aggressive, HRTX may become profitable much later than analysts predict. I’m not going to go through company-specific developments for HRTX given that this is a high-level summary, however, keep in mind that typically a biotech has lumpy cash flows which are contingent on the product type and stage of development the company is in. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the
Show less
Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HRTX alerts
High impacting Heron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HRTX
News
- Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Profit Outlook [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024PR Newswire
- Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $6.00 price target on the stock.MarketBeat
- Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain [Seeking Alpha]Seeking Alpha
HRTX
Earnings
- 3/12/24 - Beat
HRTX
Sec Filings
- 4/19/24 - Form 4
- 4/19/24 - Form PRE
- 4/19/24 - Form 4
- HRTX's page on the SEC website